Key facts
- This page summarizes Carol R. van Cleef's Form 4 filing for BTCS Inc. (BTCS).
- 1 reported transaction and 0 derivative rows are listed below.
- Accepted by SEC: 03 Jan 2024, 16:01.
Carol R. van Cleef - 31 Dec 2023 Form 4 Insider Report for BTCS Inc. (BTCS)
- Reporting relationship
- Director
- Issuer ticker
- BTCS
- Reported as of
- 31 Dec 2023
- Net transaction value
- $0
- SEC form
- 4
- Accepted by SEC
- 03 Jan 2024, 16:01:34 UTC
- Prior SEC filing
- 03 Oct 2023
- Source filing
- View source filing
- Reporting owner signature
- /s/ Carol Van Cleef
Source evidence
Original filing metadata and source links for verification.
4 source fields
Reporting owner
1 detail
Key filing fact
Carol R. van Cleef filed Form 4 for BTCS Inc. (BTCS) on 03 Jan 2024.
Change
- Previous filing in this sequence was filed on 03 Oct 2023.
- Current net transaction value: $0.
Research use
- This tells you what this filing adds before you inspect full transaction and derivative tables.
- You can trace every row back to the original SEC filing document.
Evidence
Filed on Form 4
View source filing
Ownership activity is grounded in SEC Form 4 disclosures.
Reported non-derivative transactions
Shares, units, or other non-derivative securities reported in this filing.
BTCS
transaction
Common Stock
Award
- Transaction value
- Shares
- +7,669
- Change %
- +9.3%
- Price
- Shares after
- 90,152
- Date
- 31 Dec 2023
- Ownership
- Direct
- Footnotes
- F1
* marks a reported price that did not pass the local price check.
Additional SEC filing notes
Filing notes and footnotes
Rule 10b5-1 trading plan
These transactions were reported as open-market trades under a Rule 10b5-1 plan. The plan lets an insider set trading instructions in advance, which can reduce the risk of trading while in possession of material nonpublic information.
Original filing language: transaction made pursuant to a contract, instruction, or written plan intended to satisfy Rule 10b5-1(c).
Explanation of responses 1 footnote
Footnote F1
As previously disclosed, the Issuer's Board of Directors approved an annual grant of $50,000 of common stock to the Reporting Person to be issued on a quarterly calendar basis ($12,500 per quarter).